Daniel Pascheles

Daniel Pascheles is the current advisor at the Israel Biotech Fund. Daniel has over 20 years of experience in the pharmaceutical industry, having served as Vice President at both Merck & Co. USA and Aventis Pharma Inc. During their time at Aventis, they were responsible for the development and commercialization of several blockbuster drugs, including Allegra, Claritin, and Nasacort. Daniel has played a pivotal role in the growth of the Israeli biotech industry, and their work has helped to make Israel a world leader in this field.

Daniel Pascheles received their Ph. D. in Pharmacy from ETH Zürich.